Department of Emergency Medicine, Swedish Hospital Part of NorthShore University HealthSystem, Chicago, IL, USA.
Department of Gastroenterology, Advocate Lutheran General Hospital, Park Ridge, IL, USA.
Acad Emerg Med. 2020 Aug;27(8):681-692. doi: 10.1111/acem.14053. Epub 2020 Jul 23.
Our objective was to evaluate patient-reported oxygen saturation (SpO ) using pulse oximetry as a home monitoring tool for patients with initially nonsevere COVID-19 to identify need for hospitalization.
Patients were enrolled at the emergency department (ED) and outpatient testing centers. Each patient was given a home pulse oximeter and instructed to record their SpO every 8 hours. Patients were instructed to return to the ED for sustained home SpO < 92% or if they felt they needed emergent medical attention. Relative risk was used to assess the relation between hospitalization and home SpO < 92% in COVID-19-positive patients.
We enrolled 209 patients with suspected COVID-19, of whom 77 patients tested positive for COVID-19 and were included. Subsequent hospitalization occurred in 22 of 77 (29%) patients. Resting home SpO < 92% was associated with an increased likelihood of hospitalization compared to SpO ≥ 92% (relative risk = 7.0, 95% confidence interval = 3.4 to 14.5, p < 0.0001). Home SpO < 92% was also associated with increased risk of intensive care unit admission, acute respiratory distress syndrome, and septic shock. In our cohort, 50% of patients who ended up hospitalized only returned to the ED for incidental finding of low home SpO without worsening of symptoms. One-third (33%) of nonhospitalized patients stated that they would have returned to the ED if they did not have a pulse oximeter to reassure them at home.
This study found that home pulse oximetry monitoring identifies need for hospitalization in initially nonsevere COVID-19 patients when a cutoff of SpO 92% is used. Half of patients who ended up hospitalized had SpO < 92% without worsening symptoms. Home SpO monitoring also reduces unnecessary ED revisits.
我们的目的是评估使用脉搏血氧仪监测初始非重症 COVID-19 患者的血氧饱和度(SpO ),以确定患者是否需要住院治疗。
患者在急诊科(ED)和门诊检测中心入组。每位患者均配备家用脉搏血氧仪,并被要求每 8 小时记录一次 SpO 。如果患者的 SpO 持续低于 92%或自觉需要紧急医疗关注,患者应返回 ED 就诊。采用相对风险评估 COVID-19 阳性患者中住院与家庭 SpO < 92%的关系。
我们共纳入 209 例疑似 COVID-19 患者,其中 77 例 COVID-19 检测阳性并纳入研究。77 例患者中,22 例(29%)住院。与 SpO ≥ 92%相比,家庭 SpO < 92%与住院的可能性增加相关(相对风险=7.0,95%置信区间=3.4 至 14.5,p < 0.0001)。家庭 SpO < 92%还与 ICU 入院、急性呼吸窘迫综合征和感染性休克的风险增加相关。在我们的研究队列中,50%最终住院的患者仅因在家中偶然发现 SpO 较低而返回 ED,且症状无恶化。三分之一(33%)未住院的患者表示,如果他们没有脉搏血氧仪在家中进行监测,以使其安心,他们会返回 ED。
本研究发现,当使用 SpO 92%作为截断值时,家用脉搏血氧仪监测可识别初始非重症 COVID-19 患者的住院需求。一半最终住院的患者 SpO < 92%而症状无恶化。家庭 SpO 监测还减少了不必要的 ED 复诊。